Drugs / human granulocyte colony-stimulating factor
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01995331 Background | Mar 2012 → Mar 2015 | aplastic anemia | Xiaofan Zhu | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | human granulocyte colony-stimulating factor | “Drug, human granulocyte colony-stimulating factor (rhG-CSF), 5 μg/kg/day subcutaneously starting 24 hrs after the fourth dose of cyclophosphamide” NCT01995331 ↗ |
| Known as | rhG-CSF | “Drug, human granulocyte colony-stimulating factor (rhG-CSF), 5 μg/kg/day subcutaneously starting 24 hrs after the fourth dose of cyclophosphamide” NCT01995331 ↗ |
| Modality | Protein / enzyme biologic | “human granulocyte colony-stimulating factor (rhG-CSF)” NCT01995331 ↗ |
| Route | Subcutaneous | “5 μg/kg/day subcutaneously” NCT01995331 ↗ |